PDfs files

Biomarkers

Show All

Plasma Genotyping in NSCLC: Layering in the Liquid...

Benjamin Levy, MD

Predictive and Prognostic Biomarkers for IO: Value of...

Alberto Chiappori, MD

Biosimilars Implementation in the US: A Five Year...

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Tumor Biology, Pathology, Novel Diagnostics

Tianhong “Tina” Li, MD, PhD

How to Manage Myelodysplasia: Biomarkers and Novel Treatments

Guillermo Garcia-Manero, MD

Predictive Biomarkers for Immunotherapy – Non-Small Cell Lung...

David R. Gandara, MD

Current Status of Biosimilars and Recent Approvals

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Integrating Biomarkers into Targeted Therapy and Immunotherapy Clinical...

Paul Frankel, PhD

Bladder

Show All

Updates in Kidney and Bladder Cancers

Pedro Barata, MD

Bladder Cancer Updates

Petros Grivas, MD, PhD

Immunotherapy for Kidney and Bladder Malignancies

Pedro Barata, MD, MSc

Novel Advances in Kidney and Bladder Cancers

Pedro Barata, MD

Immunotherapy in Kidney & Bladder

Pedro C. Barata MD

Kidney and Bladder Cancers as Targets for Immunotherapy

Alan J. Koletsky, MD

Moving the Needle on Bladder Cancer Survival –...

Marc Dall'Era, MD

Immunotherapy in Kidney & Bladder Cancers

Michael E. Hurwitz, MD, PhD

Immunotherapy in Kidney and Bladder Cancers

Michael E. Hurwitz, MD, PhD

Immunotherapy for the Treatment of Kidney and Bladder...

Alan J. Koletsky, MDky, MD

Bone

Show All

Allogenic Stem Cell Treatment in Post ET Myelofibrosis

Dalianie Nieves, MD

Cancer Treatment Induced Bone Loss (CTIBL)_ RANK Ligand,...

Robert E. Marx, DDS

Brain

Show All

Meningiomas, Acoustic Neuromas and Pineal Region Tumors

Sajeel Chowdhary, MD

Systemic and Combined Therapy for Brain Malignancies and...

Atif M. Hussein, MD

Bring New & Innovative Glioblastoma Treatments to the...

Sajeel Chowdhary, MD

Neural Stem Cell Based Anti-Cancer Gene Therapy for...

Jana Portnow, MD

Brain Tumors

Eric T. Wong, MD

Brain Tumors – Targeted Therapies,Vaccine and Modality Therapies

Sajeel Chowdhary, MD

Systemic Therapies for Brain Tumors

SAJEEL CHOWDHARY, MD

Breast Cancer

Show All

Breast Cancer Immunotherapy

Joyce O'Shaughnessy, MD

The Management of HER2+ Breast Cancer: A Rapidly...

Jane Meisel, MD

Endocrine Therapy in the Neoadjuvant and Adjuvant Setting:...

Vicente Valero, MD

Inhibiting CDK4/6, PIK3CA, and PARP in mBC

Stephanie Graff, MD

Breast Cancer Cases

Delia Guaqueta, MD

New Development in HER2+ Breast Cancer

Mark Pegram, MD

Update in Management of TNBC

George W. Sledge, MD

Current Practice and Future Developments in HR+ Breast...

V.K. Gadi, MD, PhD

New Approaches in the Managment of HER2+ Breast...

Sara A. Hurtvitz, MD

Triple Negative Breast Cancer: Optimal Neoadjuvant Therapy and...

Hope S. Rugo, MD

Clinical Trials

Show All

PK and PD Considerations in Early Phase Clinical...

Timothy Synold, PharmD

Understanding Multi-Cohort Trials

Susan Groshen, PhD

Phase 1 Exp Cohorts vs Phase 2 Trials

Jeffrey Longmate, PHD

Colon

Show All

Targeted Therapy for Metastatic Colon Cancers

Richard Kim, MD

Colon Cancer: Novel Therapies and Future Approaches

Ahmed Zakari, MD

Overview of Gastric and Colon Cancers

Ahmed Zakari, MD

Colon Cancer: Where Are We?

Axel Grothey, MD

Metastatic Colorectal Cancer

Caio Max S. Rocha Lima, MD

Colon Cancer – Are We Making Progress

Axel Grothey, MD

Colon Cancer State of the Art

Heinz-Josef Lenz, MD, PhD

Colorectal

Show All

Metastatic Colorectal Cancer Therapy

Richard Kim, MD

MRD Concept in CRC management: Prime Time?

Mitesh J. Borad, MD

What is New in Colorectal Cancer

John Marshall, MD

CRC Updates

Cathy Eng, MD

Metastatic Colorectal Cancer Therapy

Richard D. Kim, MD

Colorectal cancers: Where Are We Moving?

Ahmed Zakari, MD

Integrating Biomarkers and Targeted Therapy into Colorectal Management

Mitesh J. Borad, MD

Colorectal Cancer – Novel Insights andTherapies (except IO)

Luis Baez Vallecillo, MD

Colorectal Cancer State of the Science

Heinz-Josef Lenz, MD, PhD

Immunotherapy in Colorectal Cancer & MSI-High Solid Cancers

Ahmed Zakari, MD

Featured Content

Show All

Targeted and Immune Therapies in Lung Cancer

Ravi Salgia, MD, PhD

Gastrointestinal

Show All

Updates in Esophageal and Gastric Cancers

Caio Rocha Lima, MD

Esophageal and Gastric Cancer: New Developments

George A. Fisher, Jr., MD

ASCO GI 2022 Updates

Tanios Bekaii-Saab, MD

Targeted Therapy in Sarcomas and Gastrointestinal Stromal Tumors

Gina D'Amato, MD

Overview of Gastric & Esophageal Cancers

Ahmend Zakari, MD

Surgical Management of High-Risk Gastric Patients

Lourdes Mestre Valdes, APRN

Cholangiocarcinoma and Hepatocellular Cancer

Tom Reske, MD

State of the Art in Gastrointestinal Cancers

Fadwa Ali, MD

Esophageal and Gastric Cancer: New Developments

George A. Fisher, MD, PhD

Gastric, Esophagael, and Circulating Tumor Cells in GI...

Pashtoon Kasi, MD, MS

Genitourinary

Show All

Updates in Genitourinary Cancers

Sumanta K. Pal, MD

Renal Cell Cancer: Navigating a Maze of Choices

Primo N. Lara, Jr. (UCD)

Updates in Genitourinary Cancers

Mamta Parikh, MD, MS

Case Presentation – GU

Alex Niu

Targeted Therapies in Metastatic RCC Monotherapy versus Combination...

Primo N. Lara, Jr., MD

Urothelial Cancer New Strategies

Chong-xian Pan, MD, PhD, MS

How I Treat Metastatic Urothelial Cancer when IO...

Mamta Parikh, MD, MS

State of the Art – Hormone Sensitive Prostate...

David Quinn, MBBS, PhD, FRACP, FACP

Sequencing drugs in mCRPC

Sandy Srinivas, MD

Immunotherapy of Kidney and Bladder Cancer

Daniel Petrylak, MD

Geriatric

Show All

How To Handle The Onco-Geriatric Patient

Thomas M. Reske, MD, PhD, CMD, FACP

Gynecology

Show All

Immunotherapies in Gynecologic Malignancies

Thomas Herzog, MD

What is New On the Treatment of Gynecologic...

Gerardo Colon-Otero, MD

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Alexander Olawaiye, MD

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Alexander B. Olawaiye, MD

Gynecologic Malignancies

Gerardo Colon-Otero, MD

Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies

Gerardo Colon-Otero, MD

State of the Art in Gynecologic Oncology

Rebecca A. Brooks, MD

New Directions in the Management of Ovarian Cancer

Mihaela C. Cristea, MD

Targeted Therapies in Ovarian & Other Gynecologic Cancers

Thomas J. Herzog, MD

Immunotherapy in Gynecologic Malignancies

Thomas J. Herzog, MD

Head and Neck

Show All

Novel Biomaterials-Based Approaches for Head and Neck Cancer...

Simon Young, DDS, MD, PhD

Pearls and Pitfalls in Microvascular Reconstructive Fellowships

Mark K. Wax, MD

Molecular Biomarkers of Head and Neck Cancer

Chi T. Viet, DDS, PhD, MD

Anatomic and Functional / Molecular Imaging in the...

Emilio Supsupin Jr., MD

Update on Virtual Planning: Head & Neck Reconstruction

Jonathan Shum, DDS, MD

Advancements in Skin Substitutes for Head and Neck...

Jonathon S Jundt DDS,MD,FACS

Pharyngoesophageal Reconstruction

Andrew T. Huang, MD FACS

Targeted Therapy for HNSCC and Thyroid Cancer

Cesar Perez, MD

Targeted Therapy & Immunotherapy in HNSCC

Cesar Perez, MD

Immunotherapy in Head & Neck Cancer

Rajad Mudad, MD FACP

Hematologic

Show All

Indentification and Management of Tyrosine Kinase Inhibitors (TKIs)...

Josephine Previlon, MPAS, PA-C

New Therapeutic Options in the Myelodysplastic Syndromes

Brian A. Jonas, MD, PhD, FACP

Immunotherapy in Heme Malignancies

Arta M. Monjazeb, MD, PhD

Updates in Multiple Myelom

Aaron S. Rosenberg, MD, MS

Diffuse Large Cell Lymphoma – The Latest and...

Leslie Popplewell, MD, FACP

Melanoma: Beyond Checkpoint Inhibitors

Sanjiv S. Agarwala, MD

CLL & CML (a lot on the first...

Javier Pinilla-Ibarz, MD, PhD

CLL & CML (a lot on the first...

Javier Pinilla-Ibarz, MD, PhD

Chimeric Antigen Receptor (CAR) T Cell Therapy –...

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

DOACs in Cancer

Craig S. Kitchens,, MD, MACP

Hematologic Maglinencies

Show All

Updates in Stem Cell Transplantation and CAR-T Therapy...

Krishna Komanduri, MD

New Agents and New Toxicities in Malignant Hematology:...

Nicole Ianniello, PharmD

Bone Marrow Transplant and CAR T Cell Therapy...

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

New Agents and New Toxicities in Malignant Hematology:...

Nicole Ianniello, PharmD

AML and MDS: Current Status and Future Directions

Kevin Kelly (USC)

Novel Approaches for Early Stages-Locally Advanced Esophageal and...

Pedro G. Solivan, MD

Therapeutic Strategies Targeting HER2 (ERBB2)

Scott Christensen, MD

Hematology

Show All

Updates on FL and CLL from the ASH...

Mazyar Shadman, MD, MPH

DLBCL & Hodgkin’s Disease: Novel Approaches

Eduardo Sotomayor, MD

T-Cell NHL: What’s New?

Francine M. Foss, MD

Anticoagulation in the Oncology Patient

Pamela Dudkiewicz, ARPN

CLL: Novel Therapies

Javier Pinilla-Ibarz, MD

Myelodysplasia: Biomarkers, Risk Assessment and Novel Treatments

Rami Komrokji, MD

Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining...

Mohamed Kharfan-Dabaja, MD

State of the Art Management of Sickle Cell...

Oyebimpe Adesina, MD

MDS: State of the Art

Paul Koller, MD

Other Driver Mutations: cMET, B-RAF, RET, NTRK

Luis E. Raez, MD, FACP, FCCP

Immunotherapy

Show All

Management of Immune Related Adverse Events

Alicia Rigby, AOCNP

Immunotherapy for Kidney and Bladder Malignancies

Pedro Barata, MD, MSc

Toxicities in Immunotherapy

Lisa Kottschade, APRN

Adjuvant/Neo-Adjuvant Systemic Therapy

Heather Wakelee, MD

Novel Frontiers in the Use of ctDNA in...

Christian Rolfo, MD, PhD, MBA, Dr.hc

Management of Immune Related Adverse Events

Alicia Rigby, RN, MSN, FNP, AOCNP

Immunotherapy in Cancer: Next Generation Biomarkers

Peter P. Lee, MD

Statistical Considerations in Early Phase Clinical Trial Design...

Mark Krailo, PhD

Progress in CAR-T Cell Therapies

Stephen J. Forman, MD

Immunotherapy in Lung

Luis E. Raez, MD, FACP, FCCP

Kidney

Show All

Updates in Kidney and Bladder Cancers

Pedro Barata, MD

Updates in Renal Cell Carcinoma

Tian Zhang, MD, MHS

Immunotherapy for Kidney and Bladder Malignancies

Pedro Barata, MD, MSc

Immunotherapy in Kidney & Bladder Cancers

David I. Quinn, MD

Updates in Kidney and Bladder Cancers

Pedro Barata, MD, MSc

Advanced Urothelial Cancer

Sarmad Sadeghi, MD PhD

Renal Cell Cancer: Emerging Standards of Care and...

Mamta Parikh, MD, MS

Renal Cell Cancer Updates

Brian Rini, MD

Immunotherapy in Kidney & Bladder

Pedro Barata, MD, MSc

Immunotherapy in Kidney & Bladder Tumors

Michael Hurwitz, MD, PhD

Leukemia

Show All

Chronic Lymphocytic Leukemia: Practice Updates in Treatment-Naive and...

Jose Sandoval-Sus, MD

Atypical Chronic Lymphocytic Leukemia

Jose Lopez Puebla, MD

De Novo Acute Myeloid Leukemia

Hugo Fernandez, MD

Recent Advances in Acute Leukemias

Brian Jonas, MD

New Developments in CLL

Javier Pinilla-Ibarz, MD, PhD

AML: Current Status and Future Directions

George Yaghmour, MD

Chronic Lymphocytic and Myeloid Leukemias

Javier Pinilla-Ibarz, MD, PhD

Treatment-Naïve and First Relapse CLL: What Is The...

Javier Pinilla-Ibarz, MD, PhD

De Novo Acute Myeloid Leukemia

Rami Komrokji, MD

State of the Art in Acute Leukemias

Brian A. Jonas, MD, PhD

Lung

Show All

Dealing with EGFRex19del & L858R, ALK, and K-RasG12C...

Edgardo Santos, MD

Uncommon Mutations/ Fusions: EGFRex20, RET, MET, HER2, NRG1

Stephen Liu, MD

Neo-Adjuvant and Adjuvant Immunotherapy for Non-Small Cell Lung...

Luis Raez, MD

How to Choose Front- Line Therapy for Metastatic...

How to Choose Front- Line Therapy for Metastatic NSCLC Without Driver Mutations

Stage III NSCLC: Beyond the PACIFIC/ Novel Approaches

Jorge Gomez, MD

Plasma Genotyping in NSCLC: Layering in the Liquid...

Benjamin Levy, MD

Toxicity Management of Novel Agents in Lung Cancer

Khurrum Qureshi, PharmD

Roundtable Discussion

Howard (Jack) West, MD & Sandip Patel, MD

Lung Adenocarcinoma Updates

Howard (Jack) West, MD

Squamous NSCLC and Small Cell Lung Cancer Update

Sandip Patel, MD

Lymphoma

Show All

B-Cell Lymphomas: Updates and Future Directions

Eduardo Sotomayor, MD

Modern Challenges and new options for B-cell NHL

Eduardo M. Sotomayor, MD

Non-Hodgkin’s Lymphoma

Rafael Mestres, MD

Follicular Lymphoma: Novel Advances and Pathways

Nahkle Saba, MD

Optimal Therapeutic Strategies for non-Hodgkin lymphoma

Joseph Tuscano, MD

Update from ASCO/AACR/ESMO in T-cell NHL

Luis E. Fayad, MD

Modern Challenges and new options for B-cell NHL

Eduardo Sotomayor, MD

Updates in Treatment of Lymphoma

Joseph M. Tuscano, MD

Diffuse Large B-Cell Lymphoma: Updates and Future Directions

Luis E. Fayad, MD

B-cell NHL: Highlights from AACR/ASCO

Javier Pinilla-Ibarz, MD

Malignant

Show All

Cutaneous Melanoma

Kim Margolin, MD, FASCO

Malignencies

Show All

Advances in the Treatment of CNS Malignancies

Orin Bloch (UCD)

New Therapeutic Options in the Myelodysplastic Syndromes

Brian A. Jonas, MD, PhD, FACP

Immunotherapy in Heme Malignancies

Arta M. Monjazeb, MD, PhD

Updates in Multiple Myelom

Aaron S. Rosenberg, MD, MS

Diffuse Large Cell Lymphoma – The Latest and...

Leslie Popplewell, MD, FACP

Melanoma: Beyond Checkpoint Inhibitors

Sanjiv S. Agarwala, MD

CLL & CML (a lot on the first...

Javier Pinilla-Ibarz, MD, PhD

CLL & CML (a lot on the first...

Javier Pinilla-Ibarz, MD, PhD

Chimeric Antigen Receptor (CAR) T Cell Therapy –...

Mohamed A. Kharfan-Dabaja, MD, MBA, FACP

DOACs in Cancer

Craig S. Kitchens,, MD, MACP

Melanoma

Show All

Immunotherapy for Melanoma

Sanjiv Agarwala, MD

Medical Management of Advanced Melanoma

Sanjiv Agarwala, MD

Management of Non-Melanoma Skin Cancers (BCC, SCC &...

Belisario Arango, MD

Immunotherapy and Targeted Therapy in Melanoma

Sanjiv Agarwala, MD

Melanoma and Skin Cancer Updates

Meredith McKean, MD

Immunotherapy & Targeted Therapy in Melanoma

Sanjiv Agarwala, MD

Immunotherapy for Melanoma

Sanjiv Agarwala, MD

Melanoma: Metastatic and Adjuvant Therapy

Sanjiv Agarwala, MD

Melanoma: What Is the Best Sequence of Therapy?

Sanjiv Agarwala, MD

Melanoma – Novel Therapies IncludingImmunotherapy

Sanjiv S. Agarwala, MD

Myeloma

Show All

Treatment Conundrums in Myeloma: Whats New in 2022?

Sergio Giralt, MD, FACP, FASTCT

Myeloma, So Many Therapeutic Options in the Relapse...

Jonathan Kaufman, MD

Updates in Multiple Myeloma Management

Aaron Rosenberg, MD

Most Relevant News in Multiple Myeloma in 2021

Sikander Ailawadhi, MD

Multiple Myeloma

Sergio Giralt, MD

Multiple Myeloma: What Are the New Challenges?

Jonathan L. Kaufman, MD

How to Choose the Best Therapy for Relapsed...

Sikander Ailawadhi, MD

How I Treat Multiple Myeloma

Aaron Rosenberg (UCD)

What’s New in Multiple Myeloma?

Aaron Rosenberg, MD

Frontline Therapy in Myeloma – How to Decide...

Sergio Giralt, MD

Neuroendocrine

Show All

Neuroendocrine Tumors (NET): Novel Advances in Therapy

Pasquale W. Benedetto, MD

Neuroendocrine Tumors Emerging Strategies

Sukhmani Padda, MD

Novel

Show All

Cancer Care Disparities

Edith P. Mitchell, MD, FACP, FCPP

Medical Marijuana in Oncology – Myths and Reality

Dov Pickholtz, DO

A Vision for Optimizing Patient Outcomes

Charles D. Blanke, MD, FASCO

Precision Medicine in an Era of Value Based...

Vincent Chung, MD, FACP

Immune Checkpoint Inhibitors in Cancer Patients with Autoimmune...

Shivaani Kummar, MD

Patient Derived Xenograft Models

Chong-xian Pan, MD, PhD, MS

Marijuana Use in Cancer: Myths and Reality

Dov Pickholtz, DO

Legislation & Reimbursement

Ted Okon, MBA

Oral & Maxillofacial Surgery (OMFS)

Show All

Update on Medication Related Osteonecrosis of the Jaw

Kenneth E. Fleisher, DDS, FACS

Minor Salivary Gland Tumors of The Oral Cavity,...

Robert Andrew Ord. BDS MB.BCH (HONS), FRCS, FACS, MS, MBA

HPV Related Oral and Oropharyngeal Cancer – Update

Eric R. Carlson, DMD, MD, EdM, FACS

MRI Nerve Imaging And My Experience Of 30+...

John R. Zuniga, DMD, MS, PhD

Updates And Advancements In Benign Tumors Surgical And...

Waleed Zaid, DDS, MSc, FRCD(c), FACS

Advancements and Innovations in the Diagnosis and Management...

Simon Young, DDS, MD, PhD

Future Strategies for Employing Tissue Engineering in Maxillofacial...

Mark E. Wong, FACD, FACS

Nerve Grafting: Prognostic Indicators and Outcomes

Mark K. Wax, MD

Management of ORN

Ramzey Tursun, DDS FACS

Advances in Cleft Care

Phuong D. Nguyen, MD, FACS, FAAP

Oral Cancer

Show All

The New Face Of Oral Cancer

Marx, Robert

Ovarian

Show All

Targeted Therapy for Ginecology Oncology Malignancies

Thomas Herzog, MD

Ovarian and Uterine Cancer: Novel Approaches

Thomas Herzog, MD

New Directions in the Management of Ovarian Cancer

Mihaela C. Cristea, MD

Ovarian Cancer: Contemporary Management & Clinical Trial Endpoint...

Thomas J. Herzog, MD

PARP inhibitors in Ovarian Cancer

Elisabeth Diver, MD

Ovarian cancer: Contemporary Management & Clinical Trial Endpoint...

Thomas J. Herzog, MD

Pancreas

Show All

New Developments in Pancreatic Cancer

Edward J. Kim, MD, PhD

Pancreatic

Show All

Pancreatic Cancer: Emerging Strategies

Vincent Chung, MD, FACP

Pancreatic and Biliary Cancers: Moving the Bar Up

Caio Max Rocha Lima, MD

Pancreas Cancer: Bench Lab and Future Therapeutic Options

George Kim, MD

The Lois O’Grady Lectureship: Personalizing Pancreatic Cancer Medicine

David A. Tuveson MD, PhD, FAACR

Overcoming the 7 Deadly Hallmarks of Pancreatic Cancer

David A. Tuveson MD, PhD, FAACR

Updates in Cholangiocarcinoma and Pancreas Cancer

Mike Cusnir, MD

Pancreatic Cancer: Emerging Strategies

Vincent Chung, MD, FACP

Pancreatic and Biliary Cancers: Moving the Bar Up?

Caio Max S. Rocha Lima, MD, MS

Pancreatic Cancer: Emerging Strategies

Ed Kim (UCD)

Pancreas and Hepatobiliary Tract

Caio Max S. Rocha Lima, MD

Pharmacological

Show All

Access to Biosimilars and New Indications

Jorge Garcia, PharmD, MS, MHA, MBA, FACHE

Drug Brown and White Bagging: What is It...

Jorge J. García, PharmD, MS, MHA, MBA, FACHE

Biosimilars as Front-Line Options for Cancer Care

Jorge J. García, PharmD, MS, MHA, MBA, FACHE

Biosimilars, Beyond the Scientific Review

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Biosimilars as Front Line Options for Cancer Care

Jorge J. García, PharmD, MS, MHA, MBA, FACHE

Integration of Biosimilars in Oncology Care

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE

Keynote Lecture: FDA Perspective on Oncology Drug Development

Harpreet Singh, MD (FDA)

CAR-T Cells: Learning How to Deal with Complications

Jessica Unzaga, PharmD, BCPS, BCOP

Pharmacokinetics of Anti-Cancer Agents in the CNS

Tim Synold, PharmD

Prostate

Show All

Targeting Prostate Cancer in the Metastatic Setting

Mayer Fishman, MD, PhD

Castration Resistant Prostate Cancer (CRPC), Non-Metastatic & Metastatic:...

Michael Hurwitz, MD, PhD

Updates in Prostate Cancer

Ulka Vaishampayan, MD

Castration Resistant Prostate Cancer: What is the optimal...

David I. Quinn, MBBS, PhD, FRACP, FACP

State of the Art: Hormone-sensitive Prostate Cancer

Tanya Dorff, MD

Prostate and Bladder Cancer Updates

Guru P. Sonpavde, MD

Targeted Therapy in Prostate

Ulka Vaishampayan, MD

Prostate and Bladder Cancer

Daniel Petrylak, MD

Prostate Cancer (no IO): Hormonal, PARP Inhibitors and...

Ulka Vaishampayan, MD

HRPC: How to Sequence Multiple Therapies

Daniel P. Petrylak, MD

Radiation

Show All

Leveraging Radiogenomics in Cancer Care

Terence M. Williams, MD, PhD

Combination Radiation and Immunotherapy

Megan E. Daly, MD

Combining Radiotherapy with Checkpoint Inhibitors

Ignacio Castellon, MD

SRS – Cyberknife and SBRT in Oncology

Puneeth Iyengar, MD, PhD

Novel Applications of SRS in Oncology-Clinical Cases

Beatriz Amendola, MD, FACR, FACRO, FASTRO

Optimizing Immunotherapy with Radiation

Megan E. Daly, MD

Advances in Radiation Oncology

Arta M. Monjazeb, MD, PhD

Optimizing Immunotherapy with Radiation

Megan E. Daly, MD

Systemic Immunotherapy Combinations

Arta M. Monjazeb, MD, PhD

Stereotactic Radiation Therapy OligoMetastatic Disease

Ana Botero, MD

Sarcoma

Show All

Soft Tissue Sarcoma

Pasquale Benedetto, MD

Soft Tissue Sarcoma and Osteosarcoma: Novel Insights and...

Gina Z. D’Amato, MD

Emerging Combination in Sarcoma Immunotherapy

Pasquale W. Benedetto, MD

Advances in the Treatment of Soft Tissue and...

Janai Carr-Ascher (UCD)

Updates in Sarcoma Therapies

Janai Carr-Ascher, MD, PhD

Phase 1 Trials What’s New in 2019

Nam Bui, MD

Soft Tissue Sarcomas

Nam Bui, MD

Soft Tissues Sarcoma – Updates from ASCO 2019

Pasquale W. Benedetto, MD

Skin

Show All

Immunotherapy in Melanoma Skin Cancers

Sanjiv S. Agarwala, MD

Melanoma: What Else Beyond Checkpoint Inhibitor Pathway?

Jose Lutzky, MD, FACP

Novel Therapies for BCC and SCC of Skin...

John Strasswimmer, MD, PhD

Immunotherapy of Melanoma

Sanjiv S. Agarwala, MD

Treatment of Melanoma Beyond Checkpoint Inhibition

Jose Lutzky, MD, FACP

Solid Tumor

Show All

Predictive and Prognostic: Value of TMB, MSI and...

Ticiana A. Leal, MD

Management of Immunotherapy Related Adverse Events in Solid...

Alga S. Ramos Morales, PharmD, MS, BCPS, BCOP

Immunotherapy in Head and Neck Cancer

Raja Mudad, MD, FACP

Nasopharyngeal Carcinoma

A. Dimitrios Colevas, MD

Immunotherapy in Head & Neck Cancer

Simon Abi Aad, MD

Immunotherapy in Head and Neck Cancer

Cesar A. Perez, MD

Emerging Systemic Treatments for Head and Neck Cancers

A. Dimitrios Colevas, MD

PARP inhibitors in Ovarian Cancer

Elisabeth Diver, MD

Cutaneous Melanoma

Kim Margolin, MD, FASCO

Immunotherapy in Head and Neck Cancer and MSI...

Brian Hunis, MD, MBA

Supportive & Palliative Care

Show All

Integrative Oncology: Treatment Approaches for Stress in Cancer...

Ashwin Mehta, MD, MPH

Novel Innovations in Proton Therapy

Timothy Williams, MD

Survivorship and Pallative Medicine in Cancer Care

Mayra Lima, MSN, FNP-C, APRN

Integrative Oncology in Cancer Care

Ashwin Mehta, MD

Telemedicine in Cancer in the Age of COVID

Howard (Jack) West, MD

Integrative Medicine in Cancer Care What the Patients...

Ashwin Mehta, MD, MPH

Challenges in End of Life Care

Amber Thomassen, MA, MSN, APRN-BC, AOCNP

Supportive Care in Oncology: What’s New in Treating...

Mildred Flores, RN, PhD

Palliative Care and the Importance of Advanced Care...

Sarah Lowry, DNP, ACNP-BC, AOCNP, ACHPH

Supportive Care in Oncology – Anemia,Neutropenia, Emesis and...

Mildred Flores, PhD

Survivorship

Show All

Precision Medicine in Pediatric Oncology

Michelle Bustamante, PharmD

Mindfulness Practices for Cancer Survivors

Ashwin Mehta, MD, MPH

Transition to Adult Care

Pam Bolton, APRN, MS, APHON

Nutrition in Oncology Survivorship

Allison Betchel, DO, FAAP

Cancer Survivorship: A Long-Term Journey

Mayra Lima, MSN, ARNP, FNP-C

Overview of Current Cancer Screenings

Adrienne Vazquez Guerra, MSN

Updates in Targeted Therapy and Percision Oncology

Vivek Subbiah, MD

Targeted Therapy in Hepatocellular Carcinoma and Biliary Cancers

Mitesh Borad, MD

Plasma Cell Disorder

Thyra Gutierrez, MD

Overview of Current Cancer Screenings

Adrienne Vazquez, MSN

Thoracic

Show All

Oncogene-Driven NSCLC

Matthew Gubens MD

Neoadjuvant Treatment in Thoracic Surgery

Jae Kim, MD

Immune-Related Adverse Events (irAE) Checkpoint Inhibitors

Helen Shih, NP, MPH

Immunotherapy Related Adverse Reactions

Helen Shih, NP, MPH

Squamous Cell Carcinoma Standard and Novel Targets.

Mohamed K. Mohamed, MD, PhD

ALK-Altered Non-Squamous NSCLC Options and Sequence

Jacob Sands, MD

Thrombosis

Show All

Anticoagulation in Oncology: What’s New?

Craig S. Kitchens, MD, MACP

Cancer-related Bleeding and Thrombosis

Anjlee Mahajan, MD

Thymic

Show All

Management of Thyroid and Thymic Carcinomas

Belisario A. Arango, MD

Thyroid

Show All

Targeted Therapy for HNSCC and Thyroid Cancer

Cesar Perez, MD

Thyroid Cancer & Thymic Carcinoma: Recent Advances

Raja Mudad, MD

Management of Thyroid and Thymic Carcinomas

Belisario A. Arango, MD

Urothelial

Show All

Urothelial Cancers: New Strategies

Mamta Parikh (UCD)

Urothelial Cancers- New Strategies

Sandy Srinivas, MD